(1 - 10 from 25
)
Germany, U.S. in hot pursuit of messenger drug molecules - Reuters
www.reuters.com
and cost,” said CureVac co-founder and CEO Ingmar Hoerr.
CureVac Secures EUR80 Million in Series D Financing
www.prnewswire.co.uk
TUBINGEN, Germany, Sept. 18, PR Newswire UK/ -- CureVac Secures EUR80 Million in Series D Financing.
Coronavirus vaccine developer CureVac CEO to go Reuterswww.reuters.com › us-health-coronavirus-germany-usa
www.reuters.com
... a coronavirus vaccine, said on Monday its recently appointed Chief Executive Officer Ingmar Hoerr will be taking a temporary medical leave.
CureVac, Sanofi Paster in 150m-euro-plus vaccines deal - PharmaTimes
www.pharmatimes.com
Germany's CureVac and Sanofi Pasteur, the vaccines arm of Sanofi, have strengthened their partnership with a new deal that gives the latter rights to a new...
sorted by relevance / date